期刊文献+

论抗高血压药物硝苯吡啶的合成工艺

Synthesis of Nifedipine for Antihypertensive Drugs
下载PDF
导出
摘要 以乙酰乙酸甲酯、18%氨水、碳酸氢铵为原材料,经过一系列合成工艺生产的硝苯吡啶,已经成为抗高血压的重要药物之一,已经得到了众多学者的高度重视与认可。主要针对抗高血压药物硝苯吡啶的合成工艺展开深入的研究,以供相关人士的借鉴,旨在更好地提升抗高血压药物的治疗功能。 Nifedipine,which is produced by a series of synthetic processes with methyl acetoacetate,18% ammonia and ammonium bicarbonate,has become one of the most important drugs for antihypertension and has played an important role.Many scholars attach great importance to and recognition.Mainly for antihypertensive drugs nifedipine synthesis process to carry out in-depth study for the relevant parties to learn to better enhance the antihypertensive drug treatment.
出处 《化工设计通讯》 CAS 2017年第11期224-,251,共2页 Chemical Engineering Design Communications
关键词 抗高血压药物 硝苯吡啶 合成工艺 antihypertensive drug nifedipine synthesis process
  • 相关文献

二级参考文献36

  • 1刘国树.钙离子通道阻滞剂治疗高血压病新进展[J].中国药物应用与监测,2006,3(4):1-4. 被引量:10
  • 2董会奕,李秋荣,王勤,罗振国.ADD-1基因和GNB3基因多态性与原发性高血压的相关性研究[J].岭南心血管病杂志,2006,12(4):258-261. 被引量:7
  • 3张澈,涂自良,胡永芳,王启斌,程晓丽,张蓬华,周宏灏.CYP3A5基因型的差异对环孢素药代动力学影响的体外研究[J].中国药理学通报,2007,23(9):1131-1137. 被引量:9
  • 4Liu M., Li Y Citterio L, et al. A functional common polymorphism of the ABCB1 gene is associated with chronic kideny disease and hypertension in Chinese[J]. Am ,I Hypertens, 2013, 26(12): 1428-1436.
  • 5Zuo X C, Zhang W L, Yuan H, et al. ABCBI polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysis[J]. Drug Metab Pharmacokinet, 2014, 29(4): 305-311.
  • 6Kim K A, Park P W, Park J Y. Effect ofABCBI (MDRI) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects[J]. BrJ Clin Pharmacol, 2007, 63(1): 53-58.
  • 7LangaeeT Y, GongY, Yarandi H N, et al. Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil[J]. Clin Pharmacol Ther, 2007, 81 ( 3): 386-391.
  • 8Zhao Y, Zhai D, He H, et al. Effects ofCYP3A5, MDRI and CACNA1C polymnrphisms on the oral disposition and response of nimodipine in a Chinese coh;lrt[J]. Eur J Clin Pharmacol, 2009, 65( 6): 579-584.
  • 9Kim K A, Park P W, Lee O J, et al. Effect of CYP3A5*3 genotype on thepharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects[J]. Clin Pharmacol Ther, 2006, 80(6): 646-656.
  • 10Lee S J, Bell D A, Coulter S J, et al. Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative det;ective CYP3A haplotype[J]. J Pharmacol Exp Ther, 2005, 313(1): 302-309.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部